We are investing in our new pharmaceuticals manufacturing site.
November 2, 2023
We are exhibiting and partnering
November 2, 2023Pharmazac launched the new product Zaolin/Vinorelbin
Pharmazac launched the new product Zaolin/Vinorelbin the first generic version for oral use ( soft gelatin caps) in Greece.
Zaolin/Vinorelbin is a chemotherapy drug used to treat non-small cell lung cancer and breast cancer.